News

A Canadian artificial cornea clinical trial has been enhanced by a remote, real-time 3D HD video training solution.

Physician presents pearls for effective use, leading to positive outcomes for patients.

The study will evaluate the safety and tolerability of the R:GEN laser in patients with early-stage age-related macular degeneration.

Investigators at Rokote Laboratories Finland Ltd. say they selected the nasal route of delivery because the virus is transmitted through the airways, and they claim that nasal administration may induce a wider immune response than intramuscular administration.

Transient sensory-motor abnormalities are often common.

Investigators suggest that SARS-CoV-2 may diffuse from the ocular surfaces to the patient’s body, and use of a conjunctival swab may be another method of diagnosing the virus.

Physicians should evaluate which options best meet the needs of their practices.

Citing an unstable supply chain, Pfizer is discontinuing the ophthalic drops.

Treatment may facilitate sight in end-stage retinitis pigmentosa.

Topcon Corp. will purchase exclusive rights to distribute Iridex Corp.’s retina and glaucoma products, while also acquiring a common equity stake in the company. Iridex will acquire Topcon’s PASCAL product line.

Patients show impressive proptosis and diplopia responses to teprotumumab.

Baseline diabetic retinopathy severity is an important predictor of its progression in patients.

The FDA has accepted Oyster Point Pharma's New Drug Application (NDA) for its OC-01 (varenicline) nasal spray to treat dry eye disease.

Autologous serum eye drops and blood products offer hope to patients.

Women 34% less likely to receive retinal detachment repair.

Check out the latest cartoon!

Tool can help physicians detect, monitor ophthalmic disease in their patients.

Visits, elective procedures decreased as physicians responded to COVID-19 guidelines.

Physicians step-up in emergency departments during COVID-19 surge.

With funding from the National Eye Institute, the team of researchers will focus on developing a broad-spectrum immunomodulatory eye drop for patients dealing with dry eye and ocular surface disease stemming from inflammatory and immune system disorders.

The bulk of a $25 million gift from the Henry L. Hillman Foundation will drive vision care research and development through The Eye and Ear Foundation and the University of Pittsburgh Departments of Ophthalmology and Otolaryngology.

Investigators reviewing options that include bifocals, low-dose atropine drops

According to a survey by the Larry A. Green Center, in collaboration with the Primary Care Collaborative (PCC) and 3rd Conversation, primary care offers assets, including experience and relationships with patients.

Dealing with the COVID-19 virus affects everything to some degree, and investigators have found that mask wear can impact the accuracy of visual field tests.

Gene therapies to mitigate the effects of mutations that cause blindness are undergoing rapid development. Investigators have found that novel gene vectors reduce the risks associated with these procedures.

Treatment of patients with COVID-19 should include ophthalmic considerations.

Organization works to ensure clinical care and access for high-risk patients.

Dr. Bath could be the first African-American woman inducted into the Hall. As the first African-American woman to receive a medical patent, for the laserphaco probe, and the first woman to lead a post-graduate training program in ophthalmology, her experience is extensive.